Suboxone Lawsuit Update: Tooth Decay MDL 3092 (Aug 2026)

Last Updated: August 9, 2026 | Reviewed by: Legal Lawsuit Editorial Team | Primary Sources: U.S. District Court for the Northern District of Ohio (MDL 3092) and the U.S. Food & Drug Administration

Suboxone Lawsuit Update: Where the Case Stands in August 2026

As of this Suboxone lawsuit update in August 2026, claims that Suboxone sublingual film damaged patients’ teeth are still moving through federal court. They are grouped as MDL 3092: In re Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation before the U.S. District Court for the Northern District of Ohio, which has described the cases as sharing common factual questions about whether the film tends to cause dental erosion and decay. Plaintiffs claim the film was formulated to be acidic and that letting it dissolve in the mouth bathed teeth in conditions that could lead to damage. The defendants dispute these claims, and the creation of an MDL is not a finding of liability; every plaintiff still has to prove their own facts, medical causation, and damages. Orders issued in 2026 show the litigation progressing through discovery and bellwether selection, steps meant to build the evidence and pick representative cases that may eventually show how juries respond to similar claims.

How Suboxone Film Might Damage Teeth

Suboxone pairs buprenorphine with naloxone and is a common treatment for opioid use disorder. The sublingual film is meant to dissolve under the tongue or in the cheek instead of being swallowed right away. The core allegation is that this extended contact can leave enamel sitting in an acidic environment, and plaintiffs say repeated exposure can wear enamel down and eventually cause serious dental problems. This Suboxone lawsuit update matters in part because the drug at issue is a valuable tool against opioid addiction. The FDA has stressed that buprenorphine’s benefits still outweigh its dental risks, so patients should never stop prescribed Suboxone or buprenorphine without first talking with a qualified healthcare provider.

Dental Injuries Claimed in Suboxone Lawsuits

People bringing Suboxone dental claims describe a variety of problems, and the kind and seriousness of injury can vary widely between patients.

The FDA has specifically noted reports of cavities, tooth decay, mouth infections, and tooth loss in patients taking buprenorphine products that dissolve in the mouth.

The FDA Warning on Buprenorphine and Dental Problems

A key event behind every Suboxone lawsuit update came on January 12, 2022, when the U.S. Food and Drug Administration issued a safety communication about serious dental problems tied to buprenorphine products that dissolve in the mouth. The agency noted that some affected patients had no prior history of major dental trouble, and it required new warnings in prescribing information and patient medication guides. The reported problems included cavities, decay, oral infections, and tooth loss, with some patients needing extractions, root canals, oral surgery, crowns, or implants. The FDA continues to stress that buprenorphine is an important treatment for opioid use disorder and pain and that its benefits outweigh the dental risks it identified. See the FDA’s buprenorphine dental safety communication

Where Suboxone MDL 3092 Stands Now

Federal Suboxone dental litigation is concentrated in MDL 3092 in the Northern District of Ohio. An MDL gathers similar lawsuits from across the country before a single federal judge for shared pretrial proceedings, but it is not a traditional class action: each plaintiff generally keeps an individual claim and must prove their own injury, exposure, causation, and damages. Judge J. Philip Calabrese presides. His orders have covered direct filing, census procedures, document production, depositions, gathering medical records, and choosing potential bellwether plaintiffs. The court’s official MDL page summarizes the allegations as claims that the film was designed to be acidic and may cause erosion and decay when dissolved in the mouth, and that the defendants knew of the dental risk but failed to warn adequately. Visit the court’s official MDL 3092 page

Suboxone Bellwether Cases and What Comes Next

Bellwethers are representative cases drawn from a larger MDL for focused discovery and possibly trial. They don’t set the value of every Suboxone dental injury lawsuit; rather, they give both sides a preview of how evidence, causation arguments, defenses, juries, and damages may play out. Court orders from 2025 and 2026 established a record-collection pool and bellwether procedures, and discovery involving medical and dental providers continued in 2026. If bellwether cases reach trial, the outcomes could shape later settlement talks, though no single verdict can guarantee what another person’s case will be worth or how it will end.

Who Qualifies for a Suboxone Dental Injury Lawsuit?

If you used Suboxone sublingual film and later developed serious dental problems, consider having an attorney who handles these cases review your medical and dental history. Relevant factors can include:

• Using Suboxone or another qualifying buprenorphine product that dissolves in the mouth
• How long and when you took the medication
• The health of your teeth before treatment began
• When dental problems appeared after starting treatment
• How many teeth were damaged
• Enamel erosion, cavities, or decay
• Pulled or lost teeth
• Root canals, crowns, implants, or other restorations
• Pharmacy, prescription, and dental records
• The statute of limitations that applies to you

Every case is evaluated individually. Taking Suboxone by itself doesn’t create a valid claim, and no particular dental injury automatically guarantees compensation.

Records to Keep for a Suboxone Dental Claim

If you’re looking into a possible claim, hold on to records that document your medication use and dental history.

For a wider look at the litigation, see Legal Lawsuit’s Suboxone lawsuit guide, and learn how coordinated injury cases work in our mass tort and personal injury claim guide.

Suboxone Lawsuit Update: Frequently Asked Questions

Is a Suboxone dental injury lawsuit underway right now?

Yes. Lawsuits over dental injuries from Suboxone film are consolidated in federal MDL 3092 before the U.S. District Court for the Northern District of Ohio.

Which dental problems have been linked to buprenorphine products?

The FDA has received reports of cavities, tooth decay, mouth infections, and tooth loss associated with buprenorphine products that dissolve in the mouth.

What exactly is Suboxone MDL 3092?

It is the federal multidistrict litigation that coordinates lawsuits claiming Suboxone buprenorphine/naloxone film caused dental injuries.

Is this a class action?

No. MDL 3092 is multidistrict litigation, not a traditional class action. Plaintiffs generally keep their own separate claims while shared pretrial matters are handled by one federal judge.

Has Suboxone reached a global dental injury settlement?

As of this update the litigation is still active, and the fact that cases are coordinated in an MDL does not mean a global settlement exists.

What is a Suboxone dental injury lawsuit worth?

No settlement amount is guaranteed. Value depends on how severe the dental injury is, how many teeth are involved, the treatment required, the strength of medical and dental evidence, how long the medication was used, and other facts specific to the case.

Should I stop Suboxone because of the dental risk?

Don’t stop prescribed buprenorphine without talking to your healthcare provider. The FDA says the benefits for opioid use disorder and pain outweigh the dental risks it has identified.

Sources & References

• 
  U.S. District Court, Northern District of Ohio – MDL 3092
  
• 
  U.S. Food & Drug Administration – Buprenorphine Dental Safety Communication
  

Editorial Disclaimer: This page provides general information only and is not legal or medical advice. Case status and court proceedings may change, and earlier settlements or verdicts don’t guarantee any particular outcome. Talk with a healthcare professional before changing any prescribed medication.